Why is Rossari Biotech falling/rising?

As of 13-Aug, Rossari Biotech Ltd is experiencing a decline in its stock price, currently at 630.00, which reflects a decrease of 5.35 (-0.84%). The stock has been underperforming significantly, having fallen for the last six consecutive days, resulting in a total drop of 9.72% during this period. Over the past week, the stock has decreased by 5.86%, and its performance over the last month shows a decline of 10.80%. Additionally, Rossari Biotech is trading below all its moving averages, indicating a bearish trend. Despite a low debt-to-equity ratio and attractive valuation metrics, the stock's performance has been hindered by a 28.43% drop over the past year, coupled with a slight profit decline of 1%. The falling investor participation, with a 34.35% drop in delivery volume, further suggests a lack of confidence among investors.
In the broader market context, the stock's recent performance contrasts sharply with the benchmark Sensex, which has only seen a minor decline of 0.01% over the past week. While the chemicals sector has gained by 2.06%, Rossari Biotech's performance has lagged behind, underperforming its sector by 2.82%. The stock's year-to-date performance is particularly concerning, with a decline of 20.02% compared to the Sensex's increase of 3.07%. This stark difference highlights the challenges Rossari Biotech faces in regaining investor confidence amidst a generally stable market environment.